Invesco Ltd. Regenxbio Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Regenxbio Inc. stock. As of the latest transaction made, Invesco Ltd. holds 136,164 shares of RGNX stock, worth $1.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

136,164

Previous 149,412 8.87%

Holding current value

$1.15 Million

Previous $1.75 Million 18.31%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$10.49 - $14.39 $138,971 - $190,638	-13,248 Reduced 8.87%	136,164 $1.43 Million
Q2 2024 Aug 13, 2024	BUY	$11.51 - $21.53 $84,805 - $158,633	7,368 Added 5.19%	149,412 $1.75 Million
Q1 2024 May 14, 2024	SELL	$12.17 - $24.61 $50,821 - $102,771	-4,176 Reduced 2.86%	142,044 $2.99 Million
Q4 2023 Feb 12, 2024	SELL	$12.89 - $20.82 $1.12 Million - $1.81 Million	-87,027 Reduced 37.31%	146,220 $2.62 Million
Q3 2023 Nov 13, 2023	SELL	$16.46 - $19.99 $166,213 - $201,859	-10,098 Reduced 4.15%	233,247 $3.84 Million
Q2 2023 Aug 11, 2023	SELL	$17.23 - $21.71 $6.19 Million - $7.8 Million	-359,492 Reduced 59.63%	243,345 $4.86 Million
Q1 2023 May 12, 2023	SELL	$18.08 - $24.55 $55,035 - $74,730	-3,044 Reduced 0.5%	602,837 $11.4 Million
Q4 2022 Feb 13, 2023	BUY	$20.4 - $24.73 $3.82 Million - $4.64 Million	187,475 Added 44.81%	605,881 $13.7 Million
Q3 2022 Nov 14, 2022	SELL	$22.29 - $35.04 $2.22 Million - $3.49 Million	-99,514 Reduced 19.21%	418,406 $11.1 Million
Q2 2022 Aug 15, 2022	BUY	$19.35 - $35.04 $5.76 Million - $10.4 Million	297,903 Added 135.4%	517,920 $12.8 Million
Q1 2022 May 16, 2022	BUY	$24.62 - $34.31 $258,066 - $359,637	10,482 Added 5.0%	220,017 $7.3 Million
Q4 2021 Feb 14, 2022	SELL	$30.19 - $40.28 $925,685 - $1.24 Million	-30,662 Reduced 12.77%	209,535 $6.85 Million
Q3 2021 Nov 15, 2021	SELL	$29.09 - $45.68 $6.5 Million - $10.2 Million	-223,403 Reduced 48.19%	240,197 $10.1 Million
Q2 2021 Aug 17, 2021	BUY	$32.46 - $40.48 $7.64 Million - $9.52 Million	235,216 Added 102.99%	463,600 $18 Million
Q1 2021 May 17, 2021	BUY	$33.61 - $49.95 $1.56 Million - $2.31 Million	46,285 Added 25.42%	228,384 $7.79 Million
Q4 2020 Feb 16, 2021	BUY	$26.52 - $49.35 $367,063 - $683,053	13,841 Added 8.23%	182,099 $8.26 Million
Q3 2020 Nov 16, 2020	SELL	$27.01 - $40.26 $363,662 - $542,060	-13,464 Reduced 7.41%	168,258 $4.63 Million
Q2 2020 Aug 14, 2020	SELL	$27.75 - $43.44 $4.02 Million - $6.3 Million	-145,033 Reduced 44.39%	181,722 $6.69 Million
Q1 2020 May 15, 2020	SELL	$21.5 - $54.2 $3,074 - $7,750	-143 Reduced 0.04%	326,755 $10.6 Million
Q4 2019 Feb 14, 2020	BUY	$34.54 - $44.87 $265,647 - $345,095	7,691 Added 2.41%	326,898 $13.4 Million
Q3 2019 Nov 14, 2019	SELL	$31.84 - $50.88 $1.72 Million - $2.76 Million	-54,166 Reduced 14.51%	319,207 $11.4 Million
Q2 2019 Aug 14, 2019	SELL	$42.0 - $59.29 $10.4 Million - $14.7 Million	-248,294 Reduced 39.94%	373,373 $19.2 Million
Q1 2019 May 15, 2019	BUY	$40.82 - $62.45 $12,450 - $19,047	305 Added 0.05%	621,667 $35.6 Million
Q4 2018 Feb 14, 2019	BUY	$39.11 - $75.15 $24.3 Million - $46.7 Million	621,362 New	621,362 $26.1 Million

Others Institutions Holding RGNX

# of Institutions

197

Shares Held

43.2M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $366M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account